These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 76475)

  • 1. Immunological diagnosis of leukaemia and lymphoma: a World Health Organization/International Union of Immunological Societies technical report.
    Br J Haematol; 1978 Jan; 38(1):85-98. PubMed ID: 76475
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunological diagnosis of leukemia and lymphoma (materials from the international meeting of the Union of Immunological Societies of the World Health Organization)].
    Petrov RV
    Probl Gematol Pereliv Krovi; 1977 Nov; (11):40-5. PubMed ID: 339226
    [No Abstract]   [Full Text] [Related]  

  • 3. Surface markers in leukemias and lymphomas.
    Siegal FP; Filippa DA; Koziner B
    Am J Pathol; 1978 Feb; 90(2):451-60. PubMed ID: 304673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface markers define human lymphoid malignancies with differing prognoses.
    Kersey J; Coccia P; Bloomfield C; Nesbit M; McKenna R; Brunning R; Hallgren H; Gajl-Peczalska K
    Haematol Blood Transfus; 1977; 20():17-24. PubMed ID: 305392
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunologic basis for the redefinition of malignant lymphomas.
    Parker JW
    Am J Clin Pathol; 1979 Oct; 72(4 Suppl):670-86. PubMed ID: 386778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B & T markers in leukemia and lymphoma.
    Bloomfield CD
    Minn Med; 1979 Jul; 62(7):499-501. PubMed ID: 315029
    [No Abstract]   [Full Text] [Related]  

  • 7. Search for correlations between immunological and morphological criteria used to classify lymphoid leukemias and non-Hodgkin's hematosarcomas with special reference to scanning electron microscopy and T and B membrane markers.
    Belpomme D; Dantchev D; Karima AM; Lelarge N; Joseph R; Caillou B; Lafleur M; Mathé G
    Recent Results Cancer Res; 1976; (56):131-43. PubMed ID: 794955
    [No Abstract]   [Full Text] [Related]  

  • 8. Immuno-methods in diagnostic hematopathology.
    Taylor CR; Parker JW
    Methods Achiev Exp Pathol; 1981; 10():37-72. PubMed ID: 7047989
    [No Abstract]   [Full Text] [Related]  

  • 9. A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias.
    Lukes RJ; Taylor CR; Parker JW; Lincoln TL; Pattengale PK; Tindle BH
    Am J Pathol; 1978 Feb; 90(2):461-86. PubMed ID: 304674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte surface markers.
    Thomson AW
    Scott Med J; 1979 Apr; 24(2):118-20. PubMed ID: 315100
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell surface phenotype in lymphoproliferative disease.
    Aisenberg AC; Wilkes BM; Long JC; Harris NL
    Am J Med; 1980 Feb; 68(2):206-13. PubMed ID: 6965562
    [No Abstract]   [Full Text] [Related]  

  • 12. The immunological diagnosis of human leukemias and lymphomas: an overview.
    Seligmann M; Brouet JC; Preud'Homme JL
    Haematol Blood Transfus; 1977; 20():1-16. PubMed ID: 344161
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunologic markers in the differential diagnosis of non-Hodgkin's lymphomas.
    Stein H; Staudinger M; Tolksdorf G; Lennert K
    J Cancer Res Clin Oncol; 1981; 101(1):29-42. PubMed ID: 7276070
    [No Abstract]   [Full Text] [Related]  

  • 14. Lukes-Collins classification and its significance.
    Lukes RJ; Collins RD
    Cancer Treat Rep; 1977 Sep; 61(6):971-9. PubMed ID: 302740
    [No Abstract]   [Full Text] [Related]  

  • 15. B cell, T cell and monocyte origin of the guinea pig L2C leukemia, mouse lymphomas and human leukemias and lymphoblastic cell lines.
    Green I; Shevach EM; Stobo J; Frank M; Herberman R
    Adv Exp Med Biol; 1973; 29(0):491-8. PubMed ID: 4136555
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunohistochemical evaluation of hematologic malignancies.
    Miettinen M; Schwarting R; Hyun BH
    Hematol Oncol Clin North Am; 1994 Aug; 8(4):683-701. PubMed ID: 7961286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of immunological, cytochemical and immunohistochemical methods in the diagnosis of malignant lymphomas.
    Mioduszewska O; Porwit-Ksiazek A
    Mater Med Pol; 1984; 16(1):44-9. PubMed ID: 6549201
    [No Abstract]   [Full Text] [Related]  

  • 18. Current views on the diagnosis of lymphomas by surface and cytoplasmic markers.
    Lewis RE; Johnson WW; Cruse JM
    Surv Immunol Res; 1982; 1(2):162-72. PubMed ID: 6314466
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic methods in pediatric oncology.
    Favara BE
    Pediatr Clin North Am; 1976 Feb; 23(1):55-65. PubMed ID: 1083005
    [No Abstract]   [Full Text] [Related]  

  • 20. A human leukaemic cell expressing hybrid membrane phenotypes.
    Burns GF; Nash AA; Worman CP; Barker CR; Hayhoe FG; Cawley JC
    Nature; 1977 Jul; 268(5617):243-5. PubMed ID: 407477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.